News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,509 Results
Type
Article (42856)
Company Profile (268)
Press Release (694367)
Multimedia
Podcasts (101)
Webinars (20)
Section
Business (207354)
Career Advice (2151)
Deals (36019)
Drug Delivery (136)
Drug Development (82083)
Employer Resources (176)
FDA (16590)
Job Trends (15078)
News (350604)
Policy (33188)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2631)
Accelerated approval (45)
Adcomms (26)
Allergies (169)
Alliances (49941)
ALS (210)
Alzheimer's disease (1792)
Antibody-drug conjugate (ADC) (438)
Approvals (16947)
Artificial intelligence (650)
Autoimmune disease (273)
Automation (54)
Bankruptcy (368)
Best Places to Work (11693)
BIOSECURE Act (20)
Biosimilars (222)
Biotechnology (176)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (743)
Cancer (5750)
Cardiovascular disease (459)
Career advice (1827)
Career pathing (42)
CAR-T (320)
CDC (59)
Celiac Disease (3)
Cell therapy (866)
Cervical cancer (46)
Clinical research (71083)
Collaboration (2033)
Company closure (6)
Compensation (1367)
Complete response letters (80)
COVID-19 (2777)
CRISPR (106)
C-suite (1119)
Cystic fibrosis (150)
Data (7669)
Decentralized trials (3)
Denatured (30)
Depression (164)
Dermatology (81)
Diabetes (582)
Diagnostics (6953)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (317)
Drug pricing (203)
Drug shortages (33)
Duchenne muscular dystrophy (287)
Earnings (92831)
Editorial (70)
Employer branding (21)
Employer resources (155)
Events (120298)
Executive appointments (1095)
FDA (20251)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1711)
Gene editing (230)
Generative AI (54)
Gene therapy (708)
GLP-1 (1063)
Government (4829)
Grass and pollen (6)
Guidances (405)
Healthcare (19166)
HIV (77)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (288)
Immuno-oncology (90)
Indications (180)
Infectious disease (3116)
Inflammatory bowel disease (218)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (288)
Interviews (341)
IPO (16806)
IRA (50)
Job creations (3690)
Job search strategy (1516)
JPM (59)
Kidney cancer (19)
Labor market (98)
Layoffs (570)
Leadership (39)
Legal (8080)
Liver cancer (99)
Longevity (33)
Lung cancer (756)
Lymphoma (424)
Machine learning (59)
Management (59)
Manufacturing (1028)
MASH (186)
Medical device (14004)
Medtech (14114)
Mergers & acquisitions (20447)
Metabolic disorders (1488)
mRNA (201)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (412)
Neuropsychiatric disorders (106)
Neuroscience (3296)
Neurotech (1)
NextGen: Class of 2026 (6582)
Non-profit (4569)
Now hiring (77)
Obesity (698)
Opinion (297)
Ovarian cancer (214)
Pain (249)
Pancreatic cancer (298)
Parkinson's disease (359)
Partnered (33)
Patents (592)
Patient recruitment (659)
Peanut (61)
People (60497)
Pharmaceutical (61)
Pharmacy benefit managers (34)
Phase 1 (22158)
Phase 2 (31312)
Phase 3 (23315)
Pipeline (8217)
Policy (317)
Postmarket research (2611)
Preclinical (9437)
Press Release (66)
Prostate cancer (293)
Psychedelics (58)
Radiopharmaceuticals (327)
Rare diseases (1060)
Real estate (6027)
Recruiting (72)
Regulatory (25562)
Reports (56)
Research institute (2444)
Resumes & cover letters (365)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (180)
Series A (289)
Series B (212)
Service/supplier (11)
Sickle cell disease (110)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (47)
Startups (3689)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (88)
The Weekly (69)
Vaccines (1105)
Venture capital (109)
Weight loss (449)
Women's health (123)
Worklife (20)
Date
Today (201)
Last 7 days (871)
Last 30 days (3198)
Last 365 days (30452)
2026 (11436)
2025 (30391)
2024 (35467)
2023 (40363)
2022 (51469)
2021 (55994)
2020 (54431)
2019 (46951)
2018 (35380)
2017 (32494)
2016 (31941)
2015 (37950)
2014 (31730)
2013 (26769)
2012 (29003)
2011 (29675)
2010 (27735)
Location
Africa (772)
Alabama (91)
Alaska (7)
Arizona (348)
Arkansas (15)
Asia (40452)
Australia (6654)
California (13028)
Canada (3709)
China (1323)
Colorado (568)
Connecticut (571)
Delaware (398)
Europe (87782)
Florida (1952)
Georgia (421)
Hawaii (3)
Idaho (62)
Illinois (1039)
India (89)
Indiana (594)
Iowa (23)
Japan (521)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1564)
Massachusetts (9321)
Michigan (357)
Minnesota (705)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (85)
New Jersey (3458)
New Mexico (28)
New York (3419)
North Carolina (1671)
North Dakota (8)
Northern California (6503)
Ohio (393)
Oklahoma (23)
Oregon (42)
Pennsylvania (2623)
Puerto Rico (29)
Rhode Island (50)
South America (1140)
South Carolina (85)
South Dakota (2)
Southern California (5144)
Tennessee (209)
Texas (2061)
United States (46094)
Utah (389)
Vermont (1)
Virginia (310)
Washington D.C. (82)
Washington State (1044)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
737,509 Results for "ctd holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma
January 28, 2026
·
3 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy
December 23, 2025
·
4 min read
Press Releases
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
December 9, 2025
·
4 min read
Press Releases
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
March 24, 2026
·
7 min read
Press Releases
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
December 9, 2025
·
7 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
March 23, 2026
·
4 min read
Press Releases
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
April 6, 2026
·
1 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - March 18, 2026
March 18, 2026
·
4 min read
Press Releases
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
March 25, 2026
·
1 min read
1 of 73,751
Next
